Methods Descriptive study of a cohort of patients admitted to ICU with a diagnosis of acutely decompensated liver cirrhosis between the years 2010-2013. Data collected included demographics, presence of comorbidities, severity of illness (APACHE II, SOFA, MELD and CLIFSOFA), etiology as well as cirrhosis stage, reason for admission, length of stay and mortality in ICU. Descriptive statistics we...

Background and Aims: Utilization of living donor liver transplantation (LDLT) and its relationship with recipient Model for End-Stage Liver Disease (MELD) needs further evaluation in the United States (U.S.). We evaluated the association between recipient MELD score at the time of surgery and survival following LDLT. Methods: All U.S. adult LDLT recipients with MELD < 25 were evaluated using th...

Many prognostic systems have been devised to predict the outcome of liver transplantation (LT) candidates. Today, the Model for End-Stage Liver Disease (MELD) is widely used for organ allocation, but it has shown some limitations. The aim of this study was to investigate the performance of MELD compared to 5 different score models. We evaluated the prognostic ability of MELD, modified Child-Tur...

INTRODUCTION Hyponatremia complicates cirrhosis and predicts short term mortality, including adverse outcomes before and after liver transplantation. MATERIAL AND METHODS From April 1, 2008, through April 2, 2010, all adult candidates for primary liver transplantation with cirrhosis, listed in Region 11 with hyponatremia, were eligible for sodium (Na) exception. RESULTS Patients with serum ...

INTRODUCTION The Model for End-Stage Liver Disease (MELD) score introduced in 2002 has come to improve selection of patients dying in the liver transplantation waiting list. OBJECTIVE To evaluate the short-term survival in liver transplantation around the world when MELD score was applied as selection criteria. METHODS - A review has been done at the online database PubMed/ Medline/Scielo. Th...

CONTEXT Transplantation is the only cure for decompensated cirrhosis. Model for End-Stage Liver Disease (MELD) is used in liver allocation. OBJECTIVES Comparing survival of enlisted populations in pre- and post-MELD eras and estimating their long-term survival. METHODS This is a retrospective study of cirrhotics enlisted for transplantation during pre- and post-MELD eras. Survival curves we...

Background: Upper gastrointestinal (GI) hemorrhage, caused by acute esophageal variceal bleeding, is a common complication and leading cause of death in patients with cirrhosis. Therefore, predicting the risk order to employ an active management prevent rebleeding crucial. Currently, there are many prognostic scoring systems that have been proposed, but research needed find valid score which ca...

OBJECTIVE The MELD system has not yet been tested as an allocation tool for liver transplantation in the developing countries. In 2006, MELD (Model for End-stage Liver Disease) was launched as a new liver allocation system in São Paulo, Brazil. This study was designed to assess the results of the new allocation policy on waiting list mortality. METHODS The State of São Paulo liver transplant ...

BACKGROUND & AIMS Organ allocation for liver transplantation is based on prognosis, using the model for end-stage liver disease (MELD) or MELD including serum sodium (MELD-Na) score. These scores do not consider systemic inflammation and septic complications. Blood level of C-reactive protein (CRP), in addition to the MELD score, associates with mortality in patients with end-stage liver diseas...